Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      NSE to delist Kingfisher, Plethico Pharma, 16 others from May 30

      NSE to delist Kingfisher, Plethico Pharma, 16 others from May 30

      Ruby Khatun Khatun23 May 2018 9:45 AM IST
      Leading stock exchange NSE has decided to delist Vijay Mallya-promoted Kingfisher Airlines and Plethico Pharmaceuticals and 16 other companies from...
      AstraZeneca potassium drug finally approved, threatening Vifor

      AstraZeneca potassium drug finally approved, threatening Vifor

      Ruby Khatun Khatun23 May 2018 9:30 AM IST
      LONDON: The decision by U.S. regulators to finally approve AstraZeneca’s much-delayed excess potassium drug Lokelma gives the group another new...
      CCI approves Bayers acquisition of Monsanto

      CCI approves Bayer's acquisition of Monsanto

      Ruby Khatun Khatun23 May 2018 9:15 AM IST
      New Delhi: India’s competition watchdog has approved Bayer’s proposed $66-billion acquisition of US biotech firm Monsanto, subject to...
      DCGI to design vaccine specific regulatory policy

      DCGI to design vaccine specific regulatory policy

      Ruby Khatun Khatun22 May 2018 3:07 PM IST
      Hyderabad: Soon the country will get a new policy specifically for vaccines as the Drugs Controller General of India, S. Eswara Reddy has announced...
      AstraZeneca Pharma Q4 net profit at Rs 3.22 crore

      AstraZeneca Pharma Q4 net profit at Rs 3.22 crore

      Ruby Khatun Khatun22 May 2018 10:45 AM IST
      New Delhi: Drug firm AstraZeneca Pharma India reported a net profit of Rs 3.22 crore for the quarter ended March 31.The company had posted a net loss...
      Two more Fortis directors quit ahead of crucial EGM today

      Two more Fortis directors quit ahead of crucial EGM today

      Ruby Khatun Khatun22 May 2018 10:30 AM IST
      New Delhi: Fortis Healthcare Monday said its two more directors, Harpal Singh and Sabina Vaisoha, have resigned — a day ahead of a crucial meeting of...
      Glenmark Pharma gets USFDA nod for generic version of Welchol tablets

      Glenmark Pharma gets USFDA nod for generic version of Welchol tablets

      Ruby Khatun Khatun22 May 2018 10:15 AM IST
      New Delhi: Glenmark Pharma said it has received final approval from the US health regulator for Colesevelam Hydrochloride tablets, 625 mg, the generic...
      Roche drug dramatically reduces bleeds in key hemophilia tests

      Roche drug dramatically reduces bleeds in key hemophilia tests

      Ruby Khatun Khatun22 May 2018 10:00 AM IST
      LONDON: Roche’s new hemophilia drug Hemlibra dramatically reduced bleeding in a broad population of hemophilia patients, results from two clinical...
      Dova Pharmas blood disorder drug gets FDA approval

      Dova Pharma's blood disorder drug gets FDA approval

      Ruby Khatun Khatun22 May 2018 9:45 AM IST
      The U.S Food and Drug Administration (FDA) said on Monday it had approved Dova Pharmaceuticals Inc’s drug to treat low blood platelet count in chronic...
      Greek parliament sends Novartis bribe probe back to court

      Greek parliament sends Novartis bribe probe back to court

      Ruby Khatun Khatun22 May 2018 9:30 AM IST
      Athens: The Greek parliament ended a probe into alleged kickbacks paid by Swiss pharma giant Novartis to senior politicians, saying it did not have...
      Bhopal: Staff of Ziqitza Healthcare on strike over salary cut; admin justifies deduction

      Bhopal: Staff of Ziqitza Healthcare on strike over salary cut; admin justifies deduction

      Ruby Khatun Khatun21 May 2018 5:11 PM IST
      Bhopal: Staff of Ziqitza Healthcare Limited went on strike on Sunday following which 108 ambulances were off the roads in various districts of the...
      Independent director quits Fortis board ahead of stakeholders meet

      Independent director quits Fortis board ahead of stakeholders meet

      Ruby Khatun Khatun21 May 2018 10:41 AM IST
      New Delhi: Fortis Healthcare said its independent director, Lt Gen Tejinder Singh Shergill, has resigned from the board due to personal reasons.His...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok